Jan Erik Nordrehaug Selected Research

Percutaneous Coronary Intervention

1/2024	Discharge Information About Adverse Drug Reactions Indicates Lower Self-Reported Adverse Drug Reactions and Fewer Concerns in Patients After Percutaneous Coronary Intervention.
1/2023	Everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: a randomized controlled trial.
1/2021	Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT).
12/2018	Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.
1/2017	Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
1/2015	Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
4/2010	A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients.
11/2006	Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Erik Nordrehaug Research Topics

Disease

10	Coronary Artery Disease (Coronary Atherosclerosis) 05/2023 - 09/2004
10	Myocardial Infarction 01/2022 - 01/2003
9	Stable Angina 01/2020 - 05/2004
8	Inflammation (Inflammations) 01/2022 - 03/2011
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2015
6	Dementia (Dementias) 01/2021 - 01/2019
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2004
5	Cognitive Dysfunction 01/2021 - 01/2017
4	Insulin Resistance 01/2023 - 02/2015
3	ST Elevation Myocardial Infarction 01/2023 - 01/2015
3	Heart Arrest (Cardiac Arrest) 01/2022 - 04/2009
3	Frailty 02/2021 - 03/2015
3	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 01/2019
3	Heart Failure 01/2020 - 07/2010
3	Reperfusion Injury 01/2017 - 12/2013
3	Infarction (Infarctions) 03/2016 - 09/2010
3	Ischemia 05/2006 - 05/2004
2	Obesity 08/2023 - 05/2020
2	Non-ST Elevated Myocardial Infarction 05/2023 - 03/2004
2	Abdominal Obesity 01/2023 - 01/2021
2	Stroke (Strokes) 02/2021 - 01/2019
2	Ventricular Fibrillation 11/2020 - 07/2018
2	Non-alcoholic Fatty Liver Disease 05/2020 - 02/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2020 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2020 - 02/2016
2	Dyslipidemias (Dyslipidemia) 05/2020 - 01/2017
2	Thrombosis (Thrombus) 01/2020 - 01/2007
2	Delirium 11/2018 - 10/2016
2	Aortic Valve Stenosis (Aortic Stenosis) 08/2017 - 08/2008
2	Emergence Delirium 10/2016 - 03/2015
2	Atherosclerosis 02/2015 - 03/2011
2	Neoplasms (Cancer) 03/2011 - 11/2009
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Coronary Disease (Coronary Heart Disease) 05/2023
1	Endocarditis 02/2021
1	Chronic Renal Insufficiency 01/2021
1	Hemorrhage 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Fatty Liver 05/2020
1	Neuroinflammatory Diseases 01/2019
1	Hypertension (High Blood Pressure) 01/2019

Drug/Important Bio-Agent (IBA)

8	KynurenineIBA 01/2022 - 03/2011
6	Tryptophan (L-Tryptophan)FDA Link 01/2020 - 03/2011
5	ApolipoproteinsIBA 08/2023 - 01/2019
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 02/2016
4	NeopterinIBA 01/2020 - 03/2011
4	AntibodiesIBA 01/2018 - 01/2015
4	HomocysteineIBA 02/2016 - 09/2004
3	Biomarkers (Surrogate Marker)IBA 05/2023 - 03/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2015
3	LipidsIBA 01/2023 - 01/2020
3	Insulin (Novolin)FDA Link 01/2023 - 12/2013
3	InterferonsIBA 01/2020 - 03/2011
3	Vitamin B Complex (B Vitamins)IBA 11/2009 - 04/2006
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2009 - 09/2004
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2009 - 09/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2023 - 01/2020
2	C-Reactive ProteinIBA 08/2023 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 01/2023 - 01/2021
2	C-PeptideIBA 01/2023 - 01/2017
2	MetalsIBA 01/2023 - 01/2022
2	1-(carboxyethylthio)tetradecaneIBA 05/2020 - 02/2016
2	Quinolinic AcidIBA 01/2020 - 01/2019
2	CarbonIBA 01/2020 - 02/2016
2	Troponin T (Troponin T1)IBA 01/2018 - 05/2011
2	3,5-seco-4-norcholestan-5-one oxime-3-olIBA 01/2017 - 01/2015
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017 - 05/2015
2	TroponinIBA 06/2011 - 09/2010
2	MB Form Creatine KinaseIBA 09/2010 - 01/2009
2	Vitamin B 6IBA 08/2008 - 09/2004
1	vorapaxarIBA 05/2023
1	von Willebrand FactorIBA 05/2023
1	Peptide Hydrolases (Proteases)FDA Link 05/2023
1	Everolimus FDA Link 01/2023
1	Amino Acids FDA Link 01/2021
1	OilsIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	AntioxidantsIBA 05/2020
1	NAD (NADH)IBA 05/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 05/2020
1	xanthurenic acidIBA 01/2020
1	Vitamin A (Retinol)FDA LinkGeneric 01/2020
1	Choline (Choline Chloride)IBA 01/2020
1	CholesterolIBA 01/2020
1	Kynurenic Acid (Kynurenate)IBA 01/2019

Therapy/Procedure

8	Percutaneous Coronary Intervention 01/2024 - 11/2006
5	Stents 01/2023 - 01/2007
5	Transcatheter Aortic Valve Replacement 02/2021 - 03/2015
5	Therapeutics 01/2021 - 03/2004
2	Drug-Eluting Stents 01/2023 - 01/2022
2	Glycemic Control 01/2023 - 01/2021
2	Extracorporeal Membrane Oxygenation 01/2022 - 11/2020
2	Heart-Assist Devices 01/2022 - 07/2010
2	Electric Countershock (Cardioversion) 11/2020 - 07/2018
2	Secondary Prevention 08/2008 - 04/2006
2	Lasers (Laser) 05/2006 - 05/2004
2	Thrombolytic Therapy 03/2004 - 01/2003
1	Home Nursing (Nursing, Home) 02/2021
1	Assisted Circulation 11/2020